<?php include "routes.php"; ?>
<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title><?php echo $projectName ?>  |  Research  &amp; innovation</title>
    <?php include "assetCss.php"; ?>
  </head>
  <body>
    <?php include "header.php"; ?>
    <div class="innerpageBanner animated flipInX">
      <img src="images/ResearchInnovation.jpg" alt="Research Innovation">
      <div class="container">
        <div class="row">
          <div class="col-md-12 text-center">
            <h3>
            Innovation &amp; Incessant Improvement
            </h3>
          </div>
        </div>
      </div>
    </div>
    <?php include "news.php"; ?>
    <div class="container">
      <div class="row innerContent">
        <div class="col-md-3">
          <?php include "overview.php"; ?>
          <?php include "operation.php"; ?>
          <?php include "sidebarSlider.php"; ?>
          
        </div>
        <div class="col-md-9">
          <!--           <h1>Heading One</h1>
          <h2>Heading Two</h2> -->
          <h3>Research centers</h3>
          <p>
            At Gbennetti, Research and innovation are the cornerstones of its business. These are those powerful pillars that propel us to the global mass of patients offering them a helping hand in their critical stage of lives. Our Innovation provides them with a ray of hope to sustain and evolve.  This is backed with our paradigm.
            <br />
          </p>
          <p>
            <p class="brandGreenText text-center"><strong>“Innovation in its Deliverance, Continual Improvement in its Solace”</strong></p>
          </p>
          <p>
            R &amp; D is therefore indeed our DNA backbone and forms the very competent of long term sustainable business strategy and is built on the foundation of its 3 core building blocks that seamlessly integrate to create novelty in the delivery. Viz
            <ul>
              <li>Formulation or process development,</li>
              <li>Analytical development, and</li>
              <li>Packaging development </li>
            </ul>
          </p>
          <p>
            Our R&amp;D is fuelled by philosophy to bless life with unique high quality cost effective innovative product services rendered in most intrigue packaging that augments our spirit of healthy happy well being and is guided by operating motto of ‘Rendition of Ingenious Innovation from Ideation to End-to-End Implementation”.
            <br />
            <br />
            We advance leading-edge science through dynamic and collaborative approaches to bring meaningful solutions to some of the most serious health challenges. We partner and empower research programs that offer first to market innovative products as well as therapeutic equivalents that are meaningful and relevant for our global partners, markets and social communities in which we intend to operate.
            <br />
            <br />
            Our hallmark of research is our convention of establishing collaboration with extemporaneous scientists and building a culture of symbiotic consultative business relationships forging alliances with leading academic researchers and institutions around the world in coherent scientific fields that match our areas of business interests and ambitions.
          </p>
          <p>
            With a mission to remain one of the pioneering, forward-looking and technologically advanced companies in the world, our R&D team is focused on developing a quality portfolio of niche differentiated products befitting strategically identified key research focal groups. Our research and innovation focus on developing medicines that deliver strong clinical performance, provide more patient benefit and deliver significant economic value by fulfilling unmet needs around the world in specific therapy areas.
            <div>
    <div>
      <!-- Nav tabs -->
      <ul class="nav nav-tabs" role="tablist">
        <li role="presentation" class="active"><a href="#sgf" aria-controls="sgf" role="tab" data-toggle="tab">Specialty generic formulations</a></li>
        <li role="presentation"><a href="#addd" aria-controls="addd" role="tab" data-toggle="tab">Advanced drug delivery devices</a></li>
        <li role="presentation"><a href="#nddp" aria-controls="nddp" role="tab" data-toggle="tab">Novel drug delivery platforms</a></li>
      </ul>
        <!-- Tab panes -->
        <div class="tab-content">
          <div role="tabpanel" class="tab-pane active" id="sgf">
            <br>
            <p class="brandGreenText"><strong>Specialty generic formulations (SGF): Specialty branded generics in critical care segments viz.</strong></p>
            <ul>
              <li> <span>Immunologics-</span> Biosimilar Proteins (Mabs) </li>
              <li>
                <span>Cytologics -</span>Advanced cancer therapeutics
              </li>
              <li>
                <span>Inhalations -</span>MDIs, DPIs and Nasal Sprays
              </li>
              <li>
                <span>Endocrinologics –</span> Hormones, Enzymes and Peptides
              </li>
              <li>
                <span>Intensive care –</span> Cardiovascular and Neurologics.
              </li>
              <li>
                <span>Dermatologics –</span> Spot on parasiticides,
              </li>
            </ul>
            <p>
            With an outstanding human force in its grit by capitalizing on cutting edge science, state of the art technology base and knowledge intensive initiatives, GBennetti GBPL is continually on spree to develop innovative solutions that serve tomorrow’s healthcare problems today.
            </p>
          </div>
          <div role="tabpanel" class="tab-pane" id="addd">
            <br>
            <p class="brandGreenText"><strong>Advanced drug delivery devices: Highly specialized Biodevices</strong></p>
              <ul>
                <li><span>   Dermatologics-</span> Transdermal patches, Surgical implants, Surgical aids
                </li>
                <li>
                  <span>Dental–</span> Microsphere dental analogues
                </li>
                <li>
                  <span>Intensive care –</span> Bone and Skin graft materials, Cardiac implants or stents.
                </li>
              </ul>
              The vision is to lead to a product that is best in class and First in Class.
              <br/>
              GBennetti (GBPL) has partnered with leading systemic research centers to develop Advanced Drug Delivery Systems as its enhanced healthcare regimen. Our Advanced research program is engaged in developing technology platforms that not only impart enhanced clinical outcomes but also provide a paradigm shift in patient convenience and experience.
              <br/>
              <br/>
              Our endeavor is to identify significant unmet medical needs in treatment of specialized disease conditions causing major illness inconvenience or pain-gratifying patient experiences and then leverage built-in technologies to develop a highly differentiated pipeline of branded products that are fully biocompatible, safe and effective.
              <br/>
              <br/>
              Our ADDS products are affordable biodegradable engineered therapeutic solutions that have stood the test of times with proof of concept business for over the years.
          </div>
          <div role="tabpanel" class="tab-pane" id="nddp">
            <br>
            <p class="brandGreenText"><strong>NOVEL DRUG DELIVERY PLATFORMS (NDDP):</strong></p>
            Our alliances are fast progressing on following key novel delivery system based platforms viz.
            <ul>
              <li>Immediate release </li>
              <li>Modified release </li>
              <li>Mouth dissolving films (MDF) </li>
              <li> Oral dispersibles or chewables</li>
              <li>Pastes and Pellets</li>
              <li>Controlled release systems (Gastric retention /Matrix based etc)</li>
              <li>Drug-layering (Bilayered tablets) </li>
              <li>Nano-mills </li>
              <li>Taste masking</li>
              <li> Micro emulsion dispersions </li>
              <li>Long acting suspension depots </li>
            </ul>
          </div>
        </div>
    </div>

            </div>      
            <hr>      
        <p>
          Our proficient pharmaceutical research ensures a rapid turn-around of a diverse range of technology platforms in Oral, Topical, Inhalation as well as Parenteral formulations. We have proven scientific capability to deliver high quality finished dosages within defined timelines cost-effectively.
          <br/>
          <br/>
          No wonder GBennetti (GBPL) is well poised to embark a new journey in its evolution as a global specialty biopharmaceutical company, where we have not only placed future building blocks under one roof but have built a remarkable foundation to bookmark tomorrow’s shining star today.
        </p>
<?php include "usp.php"; ?>
<a href="research-innovation-capabilities.php" class="pull-right">Next - Research Innovation Capabilities <i class="glyphicon glyphicon-chevron-right"></i></a>
      </div>
    </div>
  </div>
  <?php include "footer.php"; ?>
  <?php include "assetJs.php"; ?>
